Telmisartan / ramipril (fixed combination)

Key facts

Active substance
  • telmisartan
  • ramipril (fixed combination)
Therapeutic area
Cardiovascular diseases
Decision number
P/3/2008
PIP number
Telmisartan / ramipril (fixed combination)
Pharmaceutical form(s)
Tablet
Condition(s) / indication(s)
Risk of myocardial infarction, stroke, death from cardiovascular causes, or hospitalization forcongestive heart failure in patients at high risk of developing major cardiovascular events
Route(s) of administration
Oral use
Contact for public enquiries
Boehringer Ingelheim International GmbH

Tel. +49 6132778271
E-mail: paediatrics@boehringer-ingelheim.com

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating